|
The National Institute of Allergy and Infectious Diseases (NIAID) will convene a Summit on HIV vaccine research and development on March 25, 2008, in Bethesda, MD. With the input of experts in the field, NIAID will review its HIV vaccine research portfolio and seek to determine the most appropriate balance between vaccine discovery and development.
NIAID welcomes any ongoing comments or questions concerning its HIV vaccine research and development activities at: HIVVaccineSummit@niaid.nih.gov.
Please note that participants viewing the March 25 NIAID HIV Vaccine Summit via Webcast will have the opportunity to ask questions and comment during the meeting through a separate, real-time mechanism.
Presentations
|